Implications of B10-like cell expansion in a model of impaired receptor editing
B10 样细胞扩增对受体编辑受损模型的影响
基本信息
- 批准号:9244625
- 负责人:
- 金额:$ 21.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-08 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcetatesAdoptive TransferAnimalsAntibodiesAntibody FormationAntibody-Producing CellsAntigensAreaAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB cell repertoireB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesBindingBone MarrowCell CommunicationCellsChronic Lymphocytic LeukemiaClinicalCompetenceComplicationCoupledDataDefectDiseaseEtiologyExhibitsFailureFeedbackFrequenciesGenesHumoral ImmunitiesImmune systemImmunoglobulin MImmunoglobulinsImmunophenotypingImmunosuppressionImmunosuppressive AgentsImpairmentIn VitroIncidenceInflammatory ResponseInterleukin-10IonomycinLeadLecithinLightLipopolysaccharidesLymphocytosisMediatingMembraneModelingMusMutationOutcomePathogenicityPatientsPatternPhenotypePlasma CellsPlayPopulationProductionPropertyReceptors, Antigen, B-CellRegulatory PathwayReportingRoleSiteSjogren&aposs SyndromeSpecificityStimulusT-LymphocyteTestingTransgenesTransgenic MiceWorkautoreactive B cellautoreactive T cellautoreactivitybasecytokinecytopeniaexperimental studyinsightinterleukin-21novelphorbol-12-myristatepreventreceptorresponse
项目摘要
PROJECT SUMMARY/ABSTRACT
Although B cells are best known for providing humoral immunity through the production of antigen-specific
antibodies, accumulating evidence suggests some B cell subsets can function to negatively regulate
inflammatory responses by producing the immunosuppressive cytokine IL10. Perhaps the best characterized
of these subsets is the B10 B cell, which is distinctive for its CD5+CD1dhiCD19hi phenotype and ability to
secrete IL10 in response to mitogenic stimuli. B10 B cells are thought to promote antigen-specific suppression
of autoreactive T cells through an IL10 (B cell) – IL21 (T cell) feedback loop established by cognate B cell-T
cell interactions. Interestingly, some CD5+ B cell populations have a propensity to react with membrane-
associated self-antigens and may also produce IL10 like B10 B cells. Furthermore, certain diseases
associated with expanded CD5+ B cells, such as chronic lymphocytic leukemia and Sjögren’s syndrome, show
an increased incidence of autoimmune cytopenias that occur when antibodies attack the host’s own cells.
Together, these data raise the possibility that the IL10-dependent feedback mechanism may function in
reverse to help constrain B cells reactive to membrane antigens, and that breakdown of this regulatory loop
may cause B cell-intrinsic autoimmune manifestations. We previously generated transgenic mice (called
dnRAG1 mice) which exhibit a receptor editing defect used to alter B cell receptor specificity away from self-
reactivity. These animals show an expanded CD5+ B cell population and impaired antibody production. We
have found that dnRAG1 CD5+ B cells share the immunophenotype and IL10-competence of B10 B cells,
leading us to hypothesize that a failure to successfully edit B cell receptor specificity against certain self-
antigens may cause the B cell to acquire B10-like properties to suppress B cell-intrinsic autoimmunity.
Consistent with this hypothesis, we show here that IL10-deficiency in dnRAG1 mice leads to elevated IgM
production. This hypothesis will be further tested by analyzing wild-type and dnRAG1 mice on IL10+/+ and
IL10-/- backgrounds to compare spontaneous and stimulation-induced antibody levels, autoantigen reactivity
profiles, immunoglobulin variable gene usage patterns, and the frequency of IgM antibody-producing cells. We
will also determine whether adoptively transferring CD5+ B cells from IL10+/+ dnRAG1 mice into IL10-/- dnRAG1
mice can restore immune suppression in these animals. Furthermore, we will test whether impaired receptor
editing in mice expressing a site-directed phosphatidylcholine (PtC)-specific heavy chain transgene enhances
CD5+ B cell accumulation and IL10-competence, and suppresses total or PtC-specific IgM production. The
results obtained from this study may reveal an important new mechanism for how B cell-intrinsic autoimmunity
against certain self-antigens are suppressed, and will identify autoantigens that may be subjected to tolerance
induction by receptor editing. This work may also suggest an etiology for certain autoimmune manifestations,
like cytopenias, that can arise as a clinical complication in diseases associated with expanded CD5+ B cells.
项目概要/摘要
尽管 B 细胞最出名的是通过产生抗原特异性来提供体液免疫
抗体,越来越多的证据表明一些 B 细胞亚群可以发挥负调节作用
通过产生免疫抑制细胞因子 IL10 来调节炎症反应。也许是最具特色的
这些亚群中的 B10 B 细胞因其 CD5+CD1dhiCD19hi 表型和
分泌IL10以响应有丝分裂刺激。 B10 B 细胞被认为可促进抗原特异性抑制
通过同源 B 细胞-T 建立的 IL10(B 细胞)– IL21(T 细胞)反馈环路来产生自身反应性 T 细胞
细胞相互作用。有趣的是,一些 CD5+ B 细胞群有与膜反应的倾向
相关自身抗原,也可能产生类似 B10 B 细胞的 IL10。此外,某些疾病
与 CD5+ B 细胞扩增相关,例如慢性淋巴细胞白血病和干燥综合征
当抗体攻击宿主自身细胞时,自身免疫性血细胞减少症的发生率会增加。
总之,这些数据提出了 IL10 依赖性反馈机制可能在
逆转以帮助限制 B 细胞对膜抗原的反应,并且破坏该调节环路
可能引起 B 细胞固有的自身免疫表现。我们之前生成了转基因小鼠(称为
dnRAG1 小鼠)表现出受体编辑缺陷,用于改变 B 细胞受体特异性,使其远离自身
反应性。这些动物表现出 CD5+ B 细胞群扩大和抗体产生受损。我们
发现 dnRAG1 CD5+ B 细胞与 B10 B 细胞具有相同的免疫表型和 IL10 能力,
导致我们假设未能成功编辑针对某些自身的 B 细胞受体特异性
抗原可能会导致 B 细胞获得 B10 样特性,从而抑制 B 细胞固有的自身免疫。
与这一假设一致,我们在此表明 dnRAG1 小鼠中 IL10 缺乏会导致 IgM 升高
生产。该假设将通过分析野生型和 dnRAG1 小鼠的 IL10+/+ 和
IL10-/- 背景用于比较自发抗体水平和刺激诱导的抗体水平、自身抗原反应性
概况、免疫球蛋白可变基因使用模式以及 IgM 抗体产生细胞的频率。我们
还将确定是否将 CD5+ B 细胞从 IL10+/+ dnRAG1 小鼠过继转移至 IL10-/- dnRAG1
小鼠可以恢复这些动物的免疫抑制。此外,我们将测试受体是否受损
在表达定点磷脂酰胆碱(PtC)特异性重链转基因的小鼠中进行编辑可增强
CD5+ B 细胞积累和 IL10 能力,并抑制总 IgM 或 PtC 特异性 IgM 的产生。这
这项研究获得的结果可能揭示 B 细胞内在自身免疫如何发生的重要新机制
针对某些自身抗原的抗体被抑制,并且会识别可能受到耐受的自身抗原
通过受体编辑诱导。这项工作还可能提出某些自身免疫表现的病因学,
像血细胞减少症一样,它可能是与 CD5+ B 细胞扩增相关的疾病的临床并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick C. Swanson其他文献
Receptor editing constrains development of phosphatidyl choline-specific B cells in VsubH/sub12-transgenic mice
- DOI:
10.1016/j.celrep.2022.110899 - 发表时间:
2022-06-14 - 期刊:
- 影响因子:6.900
- 作者:
Alexandra N. Worth;Victoria L. Palmer;N. Max Schabla;Greg A. Perry;Anna N. Fraser-Philbin;Patrick C. Swanson - 通讯作者:
Patrick C. Swanson
Patrick C. Swanson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick C. Swanson', 18)}}的其他基金
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10430247 - 财政年份:2021
- 资助金额:
$ 21.83万 - 项目类别:
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10302865 - 财政年份:2021
- 资助金额:
$ 21.83万 - 项目类别:
DCAF1(VprBP) regulates FoxO1 to promote Rag transcription
DCAF1(VprBP)调控FoxO1促进Rag转录
- 批准号:
9808408 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8876720 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8499380 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8688270 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8345107 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination
定义新型 E3 泛素连接酶在 V(D)J 重组中的作用
- 批准号:
8313160 - 财政年份:2011
- 资助金额:
$ 21.83万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 21.83万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 21.83万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 21.83万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 21.83万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 21.83万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 21.83万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 21.83万 - 项目类别:














{{item.name}}会员




